國際簡稱:INT IMMUNOPHARMACOL 參考譯名:國際免疫藥理學
主要研究方向:醫學-免疫學 非預警期刊 審稿周期: 約2.7個月 約7.5周
《國際免疫藥理學》(International Immunopharmacology)是一本由Elsevier出版的以醫學-免疫學為研究特色的國際期刊,發表該領域相關的原創研究文章、評論文章和綜述文章,及時報道該領域相關理論、實踐和應用學科的最新發現,旨在促進該學科領域科學信息的快速交流。該期刊是一本未開放期刊,近三年沒有被列入預警名單。該期刊享有很高的科學聲譽,影響因子不斷增加,發行量也同樣高。
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.
The subject material appropriate for submission includes:
? Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
? Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
? Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
? Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
? Agents that activate genes or modify transcription and translation within the immune response.
? Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
? Production, function and regulation of cytokines and their receptors.
? Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.
CiteScore | SJR | SNIP | CiteScore 指數 | ||||||||||||||||
8.4 | 1.167 | 0.946 |
|
名詞解釋:CiteScore 是衡量期刊所發表文獻的平均受引用次數,是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據是期刊最近4年(含計算年度)的被引次數除以該期刊近四年發表的文獻數。例如,2022年的 CiteScore 計算方法為:2022年的 CiteScore =2019-2022年收到的對2019-2022年發表的文件的引用數量÷2019-2022年發布的文獻數量 注:文獻類型包括:文章、評論、會議論文、書籍章節和數據論文。
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
是 | 否 | 醫學 | 2區 | IMMUNOLOGY 免疫學 PHARMACOLOGY & PHARMACY 藥學 | 2區 2區 |
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
否 | 否 | 醫學 | 2區 | IMMUNOLOGY 免疫學 PHARMACOLOGY & PHARMACY 藥學 | 2區 2區 |
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
否 | 否 | 醫學 | 2區 | PHARMACOLOGY & PHARMACY 藥學 IMMUNOLOGY 免疫學 | 2區 3區 |
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
否 | 否 | 醫學 | 2區 | IMMUNOLOGY 免疫學 PHARMACOLOGY & PHARMACY 藥學 | 3區 2區 |
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
否 | 否 | 醫學 | 2區 | PHARMACOLOGY & PHARMACY 藥學 IMMUNOLOGY 免疫學 | 2區 3區 |
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
否 | 否 | 醫學 | 2區 | PHARMACOLOGY & PHARMACY 藥學 IMMUNOLOGY 免疫學 | 2區 3區 |
按JIF指標學科分區 | 收錄子集 | 分區 | 排名 | 百分位 |
學科:IMMUNOLOGY | SCIE | Q2 | 51 / 181 |
72.1% |
學科:PHARMACOLOGY & PHARMACY | SCIE | Q1 | 50 / 354 |
86% |
按JCI指標學科分區 | 收錄子集 | 分區 | 排名 | 百分位 |
學科:IMMUNOLOGY | SCIE | Q1 | 32 / 181 |
82.6% |
學科:PHARMACOLOGY & PHARMACY | SCIE | Q1 | 52 / 354 |
85.45% |
Author: Jin, Xiaoxing; Wang, Xiaofei; Sun, Ji; Tan, Wuping; Zhang, Guocheng; Han, Jiapeng; Xie, Mengjie; Zhou, Liping; Yu, Zhiyao; Xu, Tianyou; Wang, Changyi; Wang, Yueyi; Zhou, Xiaoya; Jiang, Hong
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109522
Author: Luo, Yanwen; Zhu, Jiefu; Zhao, Fan; Shi, Lang; Li, Yuzhen; Wu, Xiongfei
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109563
Author: Qi, Qiufeng; Peng, Yun; Zhu, Ming; Zhang, Yaping; Bao, Yanqing; Zhang, Xiaobin; Zhang, Jianqing; Liu, Yongping
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109553
Author: Yang, Hanshan; Hu, Yuru; Kong, Deyi; Chen, Ping; Yang, Linglin
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109542
Author: Li, Na; Shi, Tianyun; Zhang, Meng; He, Yanchao; Feng, Jingjing; Mei, Zhoufang; Su, Xiao; Jie, Zhijun
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109559
Author: Huang, Jialyu; Liu, Yiqi; Zeng, Han; Tian, Lifeng; Hu, Yina; He, Jinxia; Nie, Ling; Li, You; Fang, Zheng; Deng, Weiping; Chen, Mengyi; Zhao, Xia; Ouyang, Dongxiang; Fu, Yuqing; Lin, Jiaying; Xia, Leizhen; Wu, Qiongfang
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109552
Author: Yuan, Hongyi; Wei, Shufei; Ren, Zongtao; Li, Feng; Liu, Bin; Liu, Rui; Zhang, Xiaoyu
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109202
Author: Qi, Bo; Song, Yu; Chen, Chen; Zhao, Lina; Ma, Wanjie; Meng, Shuqi; Zhuang, Xiaoli; Lin, Huayi; Liang, Jing; Cui, Yan; Xie, Keliang
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109603
Frontiers In Public Health
中科院 3區 JCR Q2
Frontiers In Pharmacology
中科院 2區 JCR Q1
Biomedicine & Pharmacotherapy
中科院 2區 JCR Q1
Discover Oncology
中科院 4區 JCR Q2
Bmc Psychiatry
中科院 2區 JCR Q2
Bmc Neurology
中科院 3區 JCR Q3
Journal Of Materials Chemistry B
中科院 3區 JCR Q1
Medcomm
中科院 3區 JCR Q1
若用戶需要出版服務,請聯系出版商:ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE。